Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia-Reference-Cited by-同舟云学术

Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia

Published:2019-09-12 Issue:2 Volume:111 Page:311-316
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Fujioka Machiko,Itonaga Hidehiro^ORCID,Kato Takeharu,Nannya Yasuhito,Hashimoto Miki,Kasai Sachie,Toriyama Eo,Kamijo Rena,Taguchi Masataka,Taniguchi Hiroaki,Sato Shinya,Atogami Sunao,Imaizumi Yoshitaka,Hata Tomoko,Moriuchi Yukiyoshi,Ogawa Seishi,Miyazaki Yasushi

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-019-02731-w.pdf

Reference19 articles.

1. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 1996;88(1):59–655.

2. Champion KM, Gilbert JG, Asimakopoulos FA, Hinshelwood S, Green AR. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 1997;97(4):920–6.

3. Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9–16.

4. Bejar R. CHIP, ICUS, CCUS and other four-letter words. Leukemia. 2017;31(9):1869–71.

5. Takahashi K, Wang F, Kantarjian H, Doss D, Khanna K, Thompson E, et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case–control study. Lancet Oncol. 2017;18(1):100–11.